Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation

Neurology

Volumn 80, Issue 18, 2013, Pages 1641-1649

  Yuan, Junhui ^a   Matsuura, Eiji ^a   Higuchi, Yujiro ^a   Hashiguchi, Akihiro ^a   Nakamura, Tomonori ^a   Nozuma, Satoshi ^a   Sakiyama, Yusuke ^a   Yoshimura, Akiko ^a   Izumo, Shuji ^b   Takashima, Hiroshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; EXON; GENE; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE IID; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MYELIN SHEATH; NERVE CONDUCTION; PHENOTYPE; PRIORITY JOURNAL; SCN94 GENE; SENSORY NERVE; SURAL NERVE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; FAMILY HEALTH; FEMALE; GENES, RECESSIVE; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; NEURAL CONDUCTION; SURAL NERVE;

EID: 84879099503     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182904fdd     Document Type: Article

References (38)

1. Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 2001;27:309-312.
2. Rotthier A, Auer-Grumbach M, Janssens K, et al. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet 2010;87:513-522.
3. Guelly C, Zhu PP, Leonardis L, et al. Targeted highthroughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet 2011;88:99-105.
4. Wright A, Dyck PJ. Hereditary sensory neuropathy with sensorineural deafness and early-onset dementia. Neurology 1995;45:560-562.
5. Hojo K, Imamura T, Takanashi M, et al. Hereditary sensory neuropathy with deafness and dementia: a clinical and neuroimaging study. Eur J Neurol 1999;6:357-361.
6. Klein CJ, Botuyan MV, Wu Y, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011;43:595-600.
7. Lafreniere RG, MacDonald ML, Dube MP, et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet 2004;74:1064-1073.
8. Coen K, Pareyson D, Auer-Grumbach M, et al. Novel mutations in the HSN2 gene causing hereditary sensory and autonomic neuropathy type II. Neurology 2006;66:748-751.
9. Kurth I, Pamminger T, Hennings JC, et al. Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet 2009;41:1179-1181.
10. Rivière JB, Ramalingam S, Lavastre V, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet 2011;89:219-230.
11. Slaugenhaupt SA, Blumenfeld A, Gill SP, et al. Tissuespecific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001;68:598-605.
12. Anderson SL, Coli R, Daly IW, et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 2001;68:753-758.
13. Axelrod FB, Hilz MJ. Inherited autonomic neuropathies. Semin Neurol 2003;23:381-390.
14. Mardy S, Miura Y, Endo F, et al. Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am J Hum Genet 1999;64:1570-1579.
15. Einarsdottir E, Carlsson A, Minde J, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet 2004;13:799-805.
16. Carvalho OP, Thornton GK, Hertecant J, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet 2011;48:131-135.
17. Edvardson S, Cinnamon Y, Jalas C, et al. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol 2012;71:569-572.
18. Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004;41:171-174.
19. Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006;52:767-774.
20. Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012;71:26-39.
21. Goldberg YP, Pimstone SN, Namdari R, et al. Human Mendelian pain disorders: a key to discovery and validation of novel analgesics. Clin Genet 2012;82:367-373.
22. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006;444:894-898.
23. Goldberg YP, MacFarlane J, MacDonald ML, et al. Loss-offunction mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007;71:311-319.
24. Ahmad S, Dahllund L, Eriksson AB, et al. A stop codon mutation in SCN9A causes lack of pain sensation. Hum Mol Genet 2007;16:2114-2121.
25. Cox JJ, Sheynin J, Shorer Z, et al. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum Mutat 2010;31:e1670-e1686.
26. Staud R, Price DD, Janicke D, et al. Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain. Eur J Pain 2011;15:223-230.
27. Nilsen KB, Nicholas AK, Woods CG, et al. Two novel SCN9A mutations causing insensitivity to pain. Pain 2009;143:155-158.
28. Schröder JM. Developmental and pathological changes at the node and paranode in human sural nerves. Microsc Res Tech 1996;34:422-435.
29. Dyck PJ, Giannini C, Lais A. Pathologic alterations of nerves. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral Neuropathy, vol. 1, 3rd ed. Philadelphia: W. B. Saunders; 1993:514-595.
30. Milne I, Bayer M, Cardle L, et al. Tablet-next generation sequence assembly visualization. Bioinformatics 2010;26:401-402.
31. Okamoto Y, Higuchi I, Sakiyama Y, et al. A new mitochondriarelated disease showing myopathy with episodic hypercreatine kinase-emia. Ann Neurol 2011;70:486-492.
32. Michiels JJ, Te Morsche RH, Jansen JB, Drenth JP. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. Arch Neurol 2005;62:1587-1590.
33. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 1995;14:1084-1090.
34. Sangameswaran L, Fish LM, Koch BD, et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 1997;272:14805-14809.
35. Rush AM, Dib-Hajj SD, Liu S, Cummins TR, Black JA, Waxman SG. A single sodium channel mutation produces hyper-or hypoexcitability in different types of neurons. Proc Natl Acad Sci USA 2006;103:8245-8250.
36. Minett MS, Nassar MA, Clark AK, et al. Distinct Nav1. 7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun 2012;3:791.
37. Weiss J, Pyrski M, Jacobi E, et al. Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature 2011;472:186-190.
38. Hoeijmakers JG, Han C, Merkies IS, et al. Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation. Brain 2012;135:345-358.